Entities / Company
DAXOR.
Czech company
- Reports this week
- 0
- Active events
- 0
- Connections
- 21
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Gone quiet
No new reports in 90+ days-
DAXOR is expanding into a Tennessee medical center, integrating BVA with on-site analyzer for heart failure services.Some support1 report
-
FDA clearance enables market access for a new device from DAXOR.Some support2 reports
-
Daxor received FDA clearance for its diagnostic and presented findings in New York City.Some support4 reports
-
DAXOR's technology was validated in Jan Bakker's study, and ATR was identified as a measure of fluid leakage technology.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around DAXOR this week
News at the entities that move DAXOR most-
FDA StructuralGeneric medicine services are seeking approval for launch from the FDA.Moves DAXOR
-
Food and Drug Administration StructuralIn 2007, CBS broadcast featured Andrews, Cordes, and Couric criticizing the Food and Drug Administration's problems.Moves DAXOR
-
New York City Shared contextJoint entities are driving a high volume of General Obligation bond issuance in New York City.Moves DAXOR
-
Kansas Shared contextMidterm challenges are affecting the political balance in Iowa and Kansas, influenced by the economic fallout from the failed war in Iran.Moves DAXOR
Connections
The 6 strongest of 21, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
DAXOR's market access and product function are formally dependent on receiving regulatory clearance from the FDA.
-
Food and Drug Administration Structural
DAXOR's analyzer requires clearance from the FDA to enable blood volume testing.
-
Duke University Medical Center Structural
Daxor's technology is validated by Duke University Medical Center research, which Daxor then uses in its public announcements.
-
American College of Cardiology Shared context
Daxor presented technology and data at American College of Cardiology events.
-
Kansas Shared context
DAXOR operates within the geographic and regulatory context of Kansas.
-
New York City Shared context
DAXOR operates within the context of New York City, utilizing it as a location for professional conferences.
History
Events by the month they beganJune 2026
4 events- DAXOR is expanding into a Tennessee medical center, integrating BVA with on-site analyzer for heart failure services.
- FDA clearance enables market access for a new device from DAXOR.
- Daxor received FDA clearance for its diagnostic and presented findings in New York City.
- DAXOR's technology was validated in Jan Bakker's study, and ATR was identified as a measure of fluid leakage technology.